Quantcast

Latest Renin-angiotensin system Stories

2013-09-16 10:36:23

Dr. David Pollock has a simple message for fellow hypertension researchers: think endothelin. In a country where better than 30 percent of adults have high blood pressure and 50-75 percent of those have salt-sensitive hypertension, he believes the powerful endothelin system, which helps the body eliminate salt, should not be essentially ignored. However, the research and clinical world focus on suppressing a better-known system, which prompts the body to hold onto salt, said Pollock,...

2012-11-28 13:06:25

An analysis of two heart failure therapies finds differing outcomes regarding improvement in survival, according to two studies appearing in the November 28 issue of JAMA. In one study, Adrian F. Hernandez, M.D., M.H.S., of the Duke Clinical Research Institute, Durham, N.C., and colleagues examined the clinical effectiveness of aldosterone antagonist therapy and associations with long-term outcomes of older patients discharged from a hospitalization for heart failure. "Aldosterone...

2012-09-10 11:01:08

Many patients with hypertension are treated with ACE inhibitors. These drugs block the angiotensin converting enzyme (ACE) that regulates the salt and water balance of the body and raises blood pressure. Recent studies by a research team led by Professor Ken Bernstein (Cedars-Sinai Medical Center, Los Angeles, California, USA) have, however, significantly broadened the enzyme´s known task spectrum: The enzyme also plays a key role in blood formation, renal development and male fertility....

2012-08-27 19:49:16

Efficacy of LCZ696, a first-in-class angiotensin receptor neprilysin inhibitor, in patients with heart failure and preserved ejection fraction The novel angiotensin receptor neprilysin inhibitor, LCZ696, demonstrated beneficial effects in heart failure patients with preserved ejection fraction (HFpEF), according to results of the PARAMOUNT (Prospective compArison of ARNI with ARB on Management Of heart failUre with preserved ejectioN fracTion) trial. Approximately half of all heart...

2011-10-25 13:06:37

Open heart surgery may no longer be the only option for third most common type of heart disease A type of medication known as angiotensin-receptor blockers could reduce risk of mortality in people with a heart disease called calcific aortic stenosis (AS) by 30 per cent over an eight-year period, Heart and Stroke Foundation researcher Dr. Philippe Pibarot told delegates at the Canadian Cardiovascular Congress. The condition is currently managed with open heart surgery. "Our discovery...

2011-10-17 14:19:45

Within the next 20 years it is expected the number of people with Alzheimer's disease (AD) will double from its current figure of half a million to one million. A new study has looked at whether certain types of drugs used to treat high blood pressure, also called hypertension, might have beneficial effects in reducing the number of new cases of Alzheimer's disease each year. The team of researchers from the University of Bristol have looked at whether drugs already being used to treat...

2011-06-23 06:25:08

(Ivanhoe Newswire)--Diabetic Kidney Disease, or DKD, is a common complication of diabetes and leading cause of chronic kidney disease and is becoming more prevalent in the U.S. About forty percent of people diagnosed with diabetes develop DKD. "Over time, the prevalence of DKD may increase due to the expanding size of the diabetes population or decrease due to the implementation of diabetes therapies," the author's of a recent study were quoted saying. Most people with DKD also have...

2011-04-15 01:00:00

DEERFIELD, Ill. and OSAKA, Japan, April 15, 2011 /PRNewswire/ -- Takeda Pharmaceutical Company Limited and its wholly-owned subsidiary, Takeda Pharmaceuticals North America, Inc., today announced that EDARBI (azilsartan medoxomil), an angiotensin II receptor blocker (ARB) approved for the treatment of hypertension, or high blood pressure, is now available by prescription for adults in U.S. pharmacies. The U.S. Food and Drug Administration (FDA) approved EDARBI on February 25, 2011 as a...

2010-09-28 07:00:00

BURLINGTON, Mass., Sept. 28 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues finds that, owing to increasing generic availability of antihypertensive agents, the hypertension drug market will decline from $26 billion in 2009 to $23 billion in 2019 in the United States, France, Germany, Italy, Spain, United Kingdom and Japan. The Pharmacor 2010 findings from the topic entitled Hypertension reveal that the...

c44aa2df67a3f8e53f905b0880dd79751
2010-04-26 13:55:00

Factors of hormone metabolism that may make African-Americans more susceptible High blood pressure also called hypertension is a major health problem that when left untreated can lead to heart disease, stroke and kidney failure. African Americans are more likely to develop high blood pressure and develop it earlier in life than Caucasians. But the reasons for the heightened risk in African Americans still remained largely unknown, although new evidence may provide some insight. Dr. TanYa...


Word of the Day
attercop
  • A spider.
  • Figuratively, a peevish, testy, ill-natured person.
'Attercop' comes from the Old English 'atorcoppe,' where 'atter' means 'poison, venom' and‎ 'cop' means 'spider.' 'Coppa' is a derivative of 'cop,' top, summit, round head, or 'copp,' cup, vessel, which refers to 'the supposed venomous properties of spiders,' says the OED. 'Copp' is still found in the word 'cobweb.'
Related